|
⚲
|
| Omri Amiravdrory | |
|---|---|
| Firm | |
| Address | 32 Page Street San Francisco, CA 94102 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| NFX SL Advantage I LP | 021-575319 | Executive Officer | of 14.6 M |
||
| NFX SST Advantage I LP | 021-574830 | Executive Officer | 4.1 M of 4.1 M |
||
| Twostep Therapeutics Inc | 021-570470 | Director | 21.1 M of 62.2 M |
||
| Immunebridge Inc | 021-542721 | Director | 5.6 M of 7.1 M |
||
| Talus Bioscience Inc | 021-521283 | Director | 9.4 M of 11.3 M |
||
| Twostep Therapeutics Inc | 021-507897 | Director | 6.5 M of 6.5 M |
||
| Resistancebio Inc | 021-504031 | Director | 12.8 M of 12.8 M |
||
| Pepper Bio Inc | 021-471702 | Director | 3.6 M of 6.0 M |
||
| Pepper Bio Inc | 021-471700 | Director | 0.1 M of 0.1 M |
||
| Pepper Bio Inc | 021-471697 | Director | 1.0 M of 1.0 M |
||
| La Jolla Labs Inc | 021-418870 | Director | 3.5 M of 3.5 M |
||
| Genome Compiler Corp | 021-167668 | Executive Officer | 0.5 M of 5.0 M |
||
| NFX Capital Management LLC | |||||
| NFX Capital Fund IV LP | 021-476624 | Executive Officer | of 450.0 M |
317.5 | |